xliv Preface
bly review process. Special thanks go to Helena  C. Kraemer, Ph.D., fo r her expert statistical
consultation; Michael B. First, M.D., for his valuable input on the coding and review of cri-
teria; and Paul S. Appelbau m, M.D., for feedback on forensic issues. Maria N. Ward,
M.Ed., RHIT, CCS-P, also helped in verifying all ICD coding. The Summit Group, which
included these consultants, the chairs of all review groups, the task force chairs, and the
APA executive officers, chaired by Dilip V. Jeste, M.D., provided le adership and vision in
helping to achieve compromise and consensus.  This level of commitment has contributed
to the balance and objectivity that  we feel are hallmarks of DSM-5.
We especially wish to recognize the outst anding APA Division of Research staff—
identified in the Task Force and Work Grou p listing at the front of this manual—who
worked tirelessly to interact with the task force, work groups, advisors, and reviewers to
resolve issues, serve as liaison s between the groups, direct and manage the academic and
routine clinical practice field trials, and record  decisions in this important process. In par-
ticular, we appreciate the support and guidan ce provided by James H. Scully Jr., M.D.,
Medical Director and CEO of the APA, throug h the years and travails of the development
process. Finally, we thank the editorial and pr oduction staff of American Psychiatric Pub-
lishing—specifically, Rebecca Rinehart, Publish er; John McDuffie, Edit orial Director; Ann
Eng, Senior Editor; Greg Kuny, Managing Editor; and Tammy Cordova, Graphics Design